The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin

Structure

Volumn 2, Issue 6, 1994, Pages 503-522

  Qin, Jun ^a   Clore, G Marius ^a   Gronenborn, Angela M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

heteronuclear multidimensional NMR; human thioredoxin; oxidized state; reduced state; solution structure

Indexed keywords

THIOREDOXIN; WATER;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; HYDROGEN BOND; MOLECULAR GENETICS; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; HUMAN; HYDROGEN BONDING; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MUTATION; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.; THIOREDOXIN; WATER;

EID: 0028773644     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(00)00051-4     Document Type: Article

References (88)

1. Thioredoxin
2. Thioredoxin and glutaredoxin systems
3. Structural and functional relations among thioredoxins of different species
4. Isolation and characterization of calf liver thioredoxin
5. 2assimilation in oxygenic photosynthesis: the ferredoxin/thioredoxin system. Perspective on its discovery, present, and future development
6. ATL-derived factor (ADF), and IL-2R/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction
7. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T- lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2
8. Thioredoxin regulates the DNA binding activity of NF-κ B by reduction of a disulfide bond involving cysteine 62
9. Oxidoreductive regulation of nuclear factor κ B
10. Differential reactivity of the functional sulfhydryl groups of cysteine-32 and cysteine-35 present in the reduced form of thioredoxin from Echerichia coli
11. Tryptophan fluorescence study of conformational transitions of the oxidized and reduced form of thioredoxin
12. 1 H NMR spectroscopy
13. 15 N NMR spectra of reduced and oxidized Escherichia coli thioredoxin
14. Effect of disulfide bridge formation on the NMR spectrum of a protein: studies on oxidized and reduced Echerichia coli thioredoxin
15. Differences in hydrogen exchange behavior between the oxidized and reduced forms of Escherichia coli thioredoxin
16. Reduction of thioredoxin significantly decreases its partial specific volume and adiabatic compressibility
17. Interaction of mutant thioredoxins of Escherichia coli with the gene 5 protein of phage T7. The redox capacity of thioredoxin is not required for stimulation of DNA polymerase activity
18. The role of thioredoxin in filamentous phage assembly
19. 15 N NMR relaxation measurements
20. A mutant thioredoxin from Escherichia coli tsnC 7007 that is nonfunctional as subunit of phage T7 DNA polymerase
21. Characterization of Escherichia coli thioredoxins with altered active site residues
22. Substitution of the conserved tryptophan 31 in Escherichia coli thioredoxin by site-directed mutagenesis and structure–function analysis
23. Mimicking the active site of protein disulfide isomerase by substitution of proline 34 in Escherichia coli thioredoxin
24. Three dimensional structure of Escherichia coli thioredoxin-S2 to 2.8 å resolution
25. Crystal structure of thioredoxin from Escherichia coli at 1.68 å resolution
26. Three-dimensional solution structure of the reduced form of Escherichia coli thioredoxin determined by nuclear magnetic resonance spectroscopy
27. High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution
28. 15 N resonance assignments and secondary structure of the human thioredoxin C62A, C69A, C73A mutant
29. 15 N labeled proteins
30. 15 N Hartmann–Hahn- multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: application to interelukin-1β
31. Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin- 1β in solution
32. 13 C-edited nuclear Overhauser enhancement spectroscopy of a protein in solution: application to interleukin 1β
33. 13 C- separated HMQC-NOESY-HMQC spectra using pulsed field gradients
34. Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy
35. 1 H nuclear magnetic resonance and distance geometry
36. The three-dimensional structure of alpha1-purothionin in solution: combined use of nuclear magnetic resonance, distance geometry and restrained molecular dynamics.
37. PROCHECK: a program to check the stereochemical quality of protein structures
38. Exploring the limits of precision and accuracy of protein structures determined by nuclear magnetic resonance spectroscopy
39. Application of molecular dynamics with interproton distance restraints to three- dimensional protein structure determination: a model study of crambin
40. Assessing the quality of solution nuclear magnetic resonance structures by complete cross-validation
41. The anatomy and taxonomy of protein structure
42. Relationship between electrostatics and redox function in human thioredoxin: characterization of pH titration shifts using two-dimensional homo- and heteronuclear NMR
43. 15 N-enriched calcineurin B
44. 2O in protein NMR. Application to sensitivity enhancement and NOE measurements
45. Localization of bound water in the solution structure of a complex of the erythroid transcription factor GATA-1 with DNA
46. Determination of the positions of bound water molecules in the solution structure of reduced human thioredoxin by heteronuclear three-dimensional nuclear magnetic resonance spectroscopy
47. Protein hydration in aqueous solution
48. Rapid recording of 2D NMR spectra without phase cycling: application to the study of hydrogen exchange in proteins
49. A common-sense approach to peak picking in two- three- and four-dimensional spectra using automatic computer analysis of contour diagrams
50. Methodological advances in protein NMR
51. 15N- enriched proteins
52. An efficient experiment for sequential backbone assignment of medium-sized isotopically enriched proteins
53. Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR
54. 15N-enriched proteins
55. 13C magnetization
56. 13C-labeled proteins
57. 13C- enriched proteins
58. 1H-NMR stereospecific assignments by conformational data-base searches
59. 13C-separated rotating frame Overhauser spectroscopy
60. βresonances in larger proteins
61. βJ couplings in isotopically enriched proteins
62. 13C
63. CCcouplings between backbone carbonyl and methyl carbons in isotopically enriched proteins
64. The high resolution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy
65. 13C J couplings in a 20 kDa protein–peptide complex
66. Optimizing recording of heteronuclear multidimensional NMR spectra using pulsed field gradients
67. Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance
68. Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics
69. Protein structures in solution by nuclear magnetic resonance and distance geometry. The polypeptide fold of the basic pancreatic trypsin inhibitor is determined using two different algorithms, DISGEO and DISMAN
70. Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins
71. 15N spectroscopy
72. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations
73. Three dimensional structure of interleukin-8 in solution
74. Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: application to crambin.
75. Sampling and efficiency of metric matrix distance geometry: a novel partial metrization algorithm
76. α coupling constants on protein structure determination by NMR
77. High-resolution solution structure of the β chemokine hMIP-1β by multidimensional NMR
78. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2
79. Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding
80. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
81. Solvation energy in protein folding and binding
82. A triple resonance NMR study of calmodulin complexed with the binding domain of skeletal muscle myosin light chain kinase: indication of a conformational change in the central helix